Kimberly-Clark (KMB)
105.18
+1.42 (1.37%)
NASDAQ · Last Trade: Nov 21st, 11:57 PM EST
Detailed Quote
| Previous Close | 103.76 |
|---|---|
| Open | 104.20 |
| Bid | 105.40 |
| Ask | 105.68 |
| Day's Range | 103.60 - 105.80 |
| 52 Week Range | 99.22 - 143.60 |
| Volume | 5,876,170 |
| Market Cap | 34.91B |
| PE Ratio (TTM) | 17.80 |
| EPS (TTM) | 5.9 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 7,575,767 |
Chart
About Kimberly-Clark (KMB)
Kimberly-Clark is a global leader in personal care products, focusing on delivering essential health and hygiene solutions to consumers around the world. The company produces a wide range of well-known brands and products, including tissues, diapers, feminine hygiene products, and incontinence items, all aimed at improving daily life and ensuring comfort and protection for families. With a strong commitment to innovation and sustainability, Kimberly-Clark continually seeks to enhance its product offerings while reducing its environmental impact, making it a trusted name in household and personal care. Read More
News & Press Releases
The risk appetite among investors is decreasing as the stock market wavers.
Via The Motley Fool · November 21, 2025
Irving, Texas – November 20, 2025 – Kimberly-Clark Corporation (NYSE: KMB), a global titan in the consumer goods arena, has once again underscored its unwavering commitment to shareholder returns by declaring a quarterly dividend of $1.26 per share. This latest declaration, consistent with previous payouts throughout the year, signals the company's
Via MarketMinute · November 20, 2025

Investing in equal parts of these five dividend stocks produces an average yield of 3.9%.
Via The Motley Fool · November 19, 2025
More Pain Ahead For Kenvue Stock? Court Signals Tylenol Autism Cases May Return Amid Retail Bearishnessstocktwits.com
Via Stocktwits · November 18, 2025
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Via StockStory · November 17, 2025
2025 has been quite the year for consumer brands, but not in a good way. The industry has underperformed for the past three years and many of the world's largest consumer brand companies are resorting to mergers & acquisitions, asset sales, and spin-offs to rejuvenate their prospects.
Via The Motley Fool · November 17, 2025
Texas judge rejects bid to block Kenvue's $398 million dividend and declines to restrict Tylenol marketing as the company faces a lawsuit over pregnancy safety claims.
Via Benzinga · November 17, 2025
Kimberly-Clark is still "oversold after the Kenvue announcement," Jenny Van Leeuwen Harrington says, citing its 5% dividend yield.
Via Benzinga · November 14, 2025
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · November 11, 2025
Cramer also believes the broader sector could be gearing up for a wave of mergers and acquisitions.
Via Stocktwits · November 11, 2025